Site #175 — Knoxville, Tennessee

Site #175 is a clinical research site located in Knoxville, Tennessee, United States 37920.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Site #175 has participated in 1 clinical trials.

Therapeutic areas: Metastatic Pancreatic Ductal Adenocarcinoma.

Sponsors: Corcept Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Knoxville

Browse all research sites in Tennessee · View every site in Knoxville

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site #175?

Site #175 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site #175 conducted?

Site #175 has 1 clinical trials on record. Their work covers Metastatic Pancreatic Ductal Adenocarcinoma.

Is Site #175 accredited by Crixeo Clinical Trials?

Site #175 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site #175?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.